Study guide

4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)

Certified Flight Paramedic FP-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Safety and Transport

1.1 Pre-Flight Operations and Equipment Stowing 1.2 Scene Safety and Landing Zone Management 1.3 In-Flight Emergency Response and Abort Protocols 1.4 Post-Incident Survival and Rescue Operations

2 Chapter 2: Flight Physiology

2.1 Gas Laws in Transport Medicine 2.2 Hypoxia: Classification and Corrective Actions 2.3 Environmental Stressors of Flight and Cabin Pressurization

3 Chapter 3: Airway, Anesthesia, and Analgesics

3.1 Advanced Airway Assessment and Difficult Airway Algorithms 3.2 Rapid Sequence Intubation (RSI) and Medication Selection 3.3 Mechanical Ventilation: Modes, Settings, and Monitoring 3.4 Transport Oxygen Systems and Duration Calculations 3.5 Anaesthetics and Induction Agents 3.6 Neuromuscular Blocking Agents 3.7 Analgesics and Vasoactive Sedative Titration

4 Chapter 4: Medical Emergencies

4.1 Respiratory Failure Pathologies (ARDS, Asthma, COPD) 4.2 Sepsis and Septic Shock Management 4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) 4.4 Toxicological Emergencies and Overdose Antidotes 4.5 Environmental Emergencies: Core Temperature Control (Hypo/Hyperthermia) 4.6 Adrenal Crisis and Incretin/Endocrine Emergencies

5 Chapter 5: Neurological Emergencies

5.1 Neurological Assessment and GCS Motor Scales 5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management 5.3 Stroke Care: Hemorrhagic vs. Ischemic Thrombectomy Candidates 5.4 Status Epilepticus Seizure Protocols 5.5 Spinal Trauma and Spinal Cord Syndromes

6 Chapter 6: Cardiac Emergencies

6.1 Acute Coronary Syndrome (ACS) and 12-Lead Interpretation 6.2 Dysrhythmias: Bradycardias and High-Grade AV Blocks 6.3 Cardiogenic Shock and Systemic Vascular Resistance (SVR) 6.4 Vasoactive Medication Titration (Norepinephrine, Epinephrine, Dopamine) 6.5 Mechanical Circulatory Support (IABP and ECMO Transport) 6.6 Post-Cardiac Arrest Care and Targeted Temperature Management

7 Chapter 7: Trauma/Burn Resuscitation

7.1 Damage Control Resuscitation and the Lethal Triad 7.2 Hemorrhage Control and Massive Transfusion Protocols (MTP) 7.3 Penetrating Thoracic Trauma and Cardiac Tamponade (Beck's Triad) 7.4 Blunt Force Deceleration Injuries (Traumatic Aortic Rupture) 7.5 Burn Physiology: Calculations (Parkland Formula) and Escharotomy

8 Chapter 8: Maternal, Fetal, and Neonatal Emergencies

8.1 Perinatal Transport and Maternal Complications 8.2 Ob/Gyn Emergencies and Emergency Delivery 8.3 Neonatal Resuscitation Program (NRP) Standards

9 Chapter 9: Pediatric Emergencies

9.1 Pediatric Assessment Triangle and Pathophysiology 9.2 Pediatric Airway and Ventilatory Management 9.3 Pediatric Pharmacology and Dosing Calculations 9.4 Pediatric Trauma and Resuscitation

10 Chapter 10: Professional Considerations

10.1 CAMTS Standards and Quality Metrics 10.2 Medical Ethics and Transport Law (EMTALA) 10.3 Crew Resource Management (CRM) and Human Factors

4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)

Key Takeaways Explain This Topic AI

DKA is characterized by hyperglycemia, anion gap metabolic acidosis, and ketogenesis, whereas HHS involves profound hyperglycemia (>600 mg/dL), severe hyperosmolality (>320 mOsm/kg), and the absence of significant ketoacidosis.

In adults with DKA or HHS, fluid resuscitation begins with isotonic saline or a balanced crystalloid at 500-1,000 mL/hr for the first 2-4 hours (2024 adult consensus), transitioning to dextrose-containing fluids when glucose falls below 250 mg/dL (DKA) or 300 mg/dL (HHS) to allow continued insulin infusion while protecting against cerebral edema.

The potassium level dictates insulin administration (adults, 2024 consensus): insulin must be held if K < 3.5 mEq/L, run with potassium supplementation if K is 3.5-5.0 mEq/L, and run without potassium if K > 5.0 mEq/L until K falls below 5.0.

Pediatric DKA carries a high risk of cerebral edema, which is managed by immediately administering Mannitol (0.5-1.0 g/kg) or 3% Hypertonic Saline and reducing fluid infusion rates.

Intubation in severe DKA is high risk; if mandatory, the ventilator must be set to match the patient's pre-intubation compensatory minute ventilation (hyperventilation) to prevent catastrophic pH drop and cardiac arrest.

Last updated: October 2026

  • Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)
  • Pathophysiology and Diagnostic Differentiation

Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) are life-threatening endocrine emergencies representing opposite ends of the spectrum of severe insulin deficiency.

Diabetic Ketoacidosis (DKA)

DKA is characterized by uncontrolled lipolysis and ketogenesis. It occurs when an absolute or relative deficiency of insulin, combined with an elevation of counter-regulatory hormones (glucagon, catecholamines, cortisol, growth hormone), prevents glucose utilization. The body shifts to utilizing free fatty acids, which are metabolized in the liver into acidic ketone bodies (primarily beta-hydroxybutyrate and acetoacetate).

Diagnostic Criteria:

Serum glucose ≥ 200 mg/dL or a known history of diabetes (about 10% present with euglycemic DKA below 200 mg/dL, often with SGLT2 inhibitors).

Arterial pH < 7.30.

Serum bicarbonate < 18 mEq/L.

Positive ketones in serum or urine.

Elevated anion gap > 10–12 mEq/L (Calculated as [Na+] - ([Cl-] + [HCO3-])).

Hyperosmolar Hyperglycemic State (HHS)

HHS occurs when there is sufficient residual insulin production to suppress lipolysis and ketogenesis, but not enough to facilitate glucose entry into tissues. Consequently, extreme hyperglycemia develops, leading to profound osmotic diuresis and severe dehydration.

Diagnostic Criteria:

Serum glucose > 600 mg/dL.

Arterial pH > 7.30.

Serum bicarbonate > 18 mEq/L.

Minimal or absent ketonuria and ketonemia.

Effective serum osmolality > 320 mOsm/kg. Calculated as: 2 * [Na+] + (Glucose / 18).

Altered mental status (stupor, lethargy, or coma) directly proportional to the degree of serum hyperosmolality.

Fluid Resuscitation Protocol

Fluid deficits are massive (3–6 L in DKA; 8–10 L in HHS). Resuscitation must proceed in a structured, phased approach to restore intravascular volume while avoiding a rapid drop in serum osmolality, which can cause cerebral edema.

Phase 1 (Intravascular Volume Expansion): Administer 0.9% Normal Saline or balanced crystalloids (e.g., Lactated Ringer's) at 500–1,000 mL/hour for the first 2–4 hours in adults without renal or cardiac compromise (smaller 250 mL boluses in older adults, heart failure, or dialysis).

Phase 2 (Tailored Fluid Choice): Determine the corrected sodium level:

Corrected [Na+] = Measured [Na+] + 1.6 * ((Serum Glucose - 100) / 100)

If corrected sodium is high or normal: Administer 0.45% NaCl (half-normal saline) at 250–500 mL/hour.

If corrected sodium is low: Administer 0.9% NaCl at 250–500 mL/hour.

Phase 3 (Dextrose Transition):

In DKA: When serum glucose falls below 250 mg/dL, add 5–10% dextrose to the IV fluid (for example, D5 1/2 NS at 150–250 mL/hour). This allows the continued insulin infusion required to clear ketones and close the anion gap while preventing hypoglycemia.

In HHS: When serum glucose falls below 300 mg/dL, transition to D5 1/2 NS to prevent rapid intracranial osmotic shifts.

Insulin and Electrolyte Management

Insulin therapy lowers blood glucose, inhibits lipolysis, and stops ketone production. However, it must be carefully timed with electrolyte correction:

The Potassium Rule (CRITICAL):

Potassium < 3.5 mEq/L (adults, 2024 consensus): DO NOT administer insulin! Insulin shifts potassium into cells, which can cause life-threatening hypokalemia and cardiac arrest. Hold insulin, administer IV potassium chloride at about 10 mEq/hour until the serum potassium rises above 3.5 mEq/L.

Potassium 3.5–5.0 mEq/L: Administer insulin infusion and add 20–30 mEq of potassium chloride to each liter of IV maintenance fluids to maintain serum potassium between 4.0 and 5.0 mEq/L.

Potassium > 5.0 mEq/L: Administer insulin infusion. Do not add potassium to the IV fluids until it falls below 5.0. Recheck serum potassium 2 hours after insulin starts, then every 4 hours.

Insulin Dosing: Initiate a continuous infusion of Regular Insulin at 0.1 units/kg/hour (e.g., 7 units/hr for a 70 kg patient). A bolus of 0.1 units/kg is optional but not required. The target rate of glucose decline is 50–75 mg/dL/hour. If the glucose does not fall by at least 50 mg/dL in the first hour, double the insulin rate.

Sodium Bicarbonate: Routine administration is not recommended as it can worsen intracellular acidosis, shifts the oxygen-hemoglobin dissociation curve to the left, and may increase the risk of cerebral edema. Consider it only if the pH is < 7.0. Administer 100 mmol sodium bicarbonate over 2 hours with 20 mEq KCl.

Pediatric DKA and Cerebral Edema

Pediatric patients are at high risk for cerebral edema, which carries a 20–25% mortality rate.

Risk Factors: Rapid fluid administration, young age, new-onset diabetes, and severe acidosis.

Clinical Presentation: Headache, bradycardia, lethargy, pupillary changes, and rising blood pressure (Cushing's triad).

Treatment: Immediately administer Mannitol (0.5–1.0 g/kg IV over 20 minutes) or Hypertonic Saline (3% NaCl, 2.5–5 mL/kg over 10–15 minutes). Slow down the fluid administration rate by one-third.

Airway Management in Severe Acidosis

Intubating a patient in DKA is a high-risk procedure with high mortality. The patient’s respiratory system is compensating for severe metabolic acidosis via hyperventilation (Kussmaul breathing) to blow off CO2.

The Hazard: During the period of induction and paralysis (apnea), the patient's PaCO2 will rapidly rise. A small increase in PaCO2 can cause the pH to drop catastrophically (e.g., from 6.95 to 6.80), leading to cardiac arrest.

Management: Avoid intubation if at all possible. If intubation is mandatory, the transport clinician must set the ventilator to match the patient’s pre-intubation minute ventilation (high respiratory rate of 30–40 breaths/min and high tidal volume) to maintain a low PaCO2 (often 10–20 mmHg) until the acidosis resolves.

Diagnostic Comparison Table

  • Feature Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
  • Primary Population Type 1 Diabetes (typically) Type 2 Diabetes (typically older adults)
  • Serum Glucose ≥ 200 mg/dL or known diabetes (can be < 200) > 600 mg/dL (often 800–1200+)
  • Arterial pH < 7.30 > 7.30
  • Serum Bicarbonate < 18 mEq/L > 18 mEq/L
  • Serum Osmolality Variable (often < 320 mOsm/kg) > 320 mOsm/kg
  • Ketones (Serum/Urine) Strongly positive Absent or trace
  • Anion Gap Elevated (> 12 mEq/L) Normal or minimally elevated
  • Fluid Deficit 3–6 Liters 8–10 Liters
  • Mental Status Alert to lethargic Stupor or coma common

Loading diagram... DKA/HHS Potassium and Insulin Algorithm